Loading…
GeneDx Holdings Corp. is projected to rise to $112.65 by 2027, a +62% move from its current price of $69.39. WGS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $66.56 | $69.41 | $72.38 | +0.02% |
| Jul 13 | $65.43 | $69.42 | $73.66 | +0.05% |
| Jul 14 | $64.58 | $69.44 | $74.67 | +0.07% |
| Jul 15 | $63.87 | $69.46 | $75.53 | +0.10% |
| Jul 16 | $63.26 | $69.48 | $76.30 | +0.12% |
| Jul 17 | $62.71 | $69.49 | $77.01 | +0.15% |
| Jul 18 | $62.21 | $69.51 | $77.66 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $62.21 | $69.51 | $77.66 | +0.17% |
| Week 2 | $59.52 | $69.63 | $81.45 | +0.34% |
| Week 3 | $57.56 | $69.75 | $84.52 | +0.52% |
| Week 4 | $55.97 | $69.87 | $87.22 | +0.69% |
| Week 5 | $54.62 | $69.99 | $89.69 | +0.86% |
| Week 6 | $53.43 | $70.11 | $92.00 | +1.04% |
| Week 7 | $52.37 | $70.23 | $94.18 | +1.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GeneDx Holdings Corp. is a healthcare company in the genomics space that provides genetic testing services with a focus on pediatric and rare disease diagnostics, including whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.
GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
GeneDx Holdings Corp. operates in the healthcare sector with a focus on genomics-based diagnostics. The stock is currently priced at $68.67 and carries a market cap of $2.04B, with a rank of 2024.
From a technical perspective, the 30-day picture is bullish with RSI14 at 70, the SMA50 at $54.75, and the SMA200 at $98.05. Nearby support sits at $38.85 and resistance at $68.67. The 30-day price range runs from $50.22 to $93.91, reflecting notable volatility within the period.
The asset shows high volatility by design (annualized volatility of 90). Overall, the price outlook blends near-term fluctuation with longer-term upside potential as reflected in the yearly forecast sequence.
A major floor 50.3% below — a decisive break under it would weaken the trend.
The nearest floor, 27.7% below — buyers have tended to step in here.
The nearest ceiling, 3.3% above — a clean break opens room to run.
A major ceiling 36.2% above — clearing it would confirm fresh momentum.
Key WGS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of WGS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $66.99 | Buy | $67.01 | Buy |
| MA 10 | $68.18 | Buy | $66.55 | Buy |
| MA 20 | $64.29 | Buy | $64.01 | Buy |
| MA 50 | $54.92 | Buy | $61.47 | Buy |
| MA 100 | $64.00 | Buy | $68.57 | Buy |
| MA 200 | $95.16 | Sell | $79.98 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.59 | Neutral |
| Stoch RSI (14) | 21.45 | Neutral |
| CCI (20) | 20.84 | Neutral |
| Williams %R (14) | -37.26 | Info |
| MACD (12,26,9) | -0.21 | Sell |
| ROC (12) | 13.02 | Buy |
| Bollinger %B (20,2) | 0.57 | Neutral |
| Stochastic %K (14) | 62.74 | Neutral |
| TRIX (15) | 1.00 | Buy |
| Awesome (5,34) | 7.90 | Buy |
| Ultimate (7,14,28) | 49.46 | Neutral |
| Momentum (10) | -3.03 | Sell |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 66.15 | Buy |
| ADX (14) | 18.80 | Neutral |
| ATR (14) | 2.61 | Info |
The near-term technical picture is bullish, supported by a bullish sentiment in the indicators. RSI14 sits at 70, suggesting strong momentum, while the 50-day simple moving average sits at $54.75 and the 200-day simple moving average sits at $98.05.
Key support is indicated at $38.85 and resistance at $68.67, with the 30-day range spanning from $50.22 to $93.91. This range illustrates a broad trading channel in the recent month and highlights upside potential relative to the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $34.51 | $69.39 | $96.99 | 0% | Neutral | |
| $85.22 | $112.65 | $159.91 | +62% | Bullish | |
| $117.96 | $163.18 | $244.16 | +135% | Bullish | |
| $125.33 | $180.15 | $280.73 | +160% | Bullish | |
| $135.84 | $202.07 | $325.73 | +191% | Bullish | |
| $145.07 | $222.75 | $369.74 | +221% | Bullish | |
| $160.72 | $254.25 | $433.19 | +266% | Bullish | |
| $197.50 | $321.44 | $560.66 | +363% | Bullish | |
| $243.11 | $406.63 | $724.61 | +486% | Bullish | |
| $284.29 | $488.24 | $887.45 | +604% | Bullish | |
| $433.45 | $842.73 | $1,662.65 | +11.1x | Bullish | |
| $692.49 | $1,538.86 | $3,411.66 | +21.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $34.51 | $69.39 | $87.91 | +0.00% |
| August 2026 | $61.97 | $74.23 | $92.07 | +6.97% |
| September 2026 | $58.60 | $70.96 | $89.49 | -4.40% |
| October 2026 | $58.18 | $71.12 | $90.94 | +0.22% |
| November 2026 | $60.61 | $74.68 | $96.60 | +5.00% |
| December 2026 | $59.76 | $74.19 | $96.99 | -0.65% |
Click any year to see its month-by-month WGS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, WGS is projected to trade between $34.51 and $96.99, averaging $69.39 — a potential gain of 0% from today's $69.39. Price action looks broadly range-bound.
GeneDx Holdings Corp.'s 2027 outlook centres on $112.65, within a $85.22 to $159.91 range. That is up +62% on the projected 2026 average. That marks a +62% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, WGS could reach as high as $244.16, with a base case around $163.18 and support toward $117.96 — roughly +135% from $69.39. Momentum favours further upside here.
Expect WGS to range from $125.33 to $280.73 through 2029. The $180.15 average target implies a +160% move from current prices. That is up +10% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The WGS price prediction for 2030 points to an average of $202.07 (low $135.84, high $325.73) — a potential gain of +191% on today's $69.39. Momentum favours further upside here.
In 2031, WGS is projected to trade between $145.07 and $369.74, averaging $222.75 — a potential gain of +221% from today's $69.39. That is up +10% on the projected 2030 average. Buyers look set to stay in control over this stretch.
GeneDx Holdings Corp.'s 2032 outlook centres on $254.25, within a $160.72 to $433.19 range. That is up +14% on the projected 2031 average. That marks a +266% change versus current levels. Momentum favours further upside here.
By 2033, WGS could reach as high as $560.66, with a base case around $321.44 and support toward $197.50 — roughly +363% from $69.39. Buyers look set to stay in control over this stretch.
Expect WGS to range from $243.11 to $724.61 through 2034. The $406.63 average target implies a +486% move from current prices. That is up +26% on the projected 2033 average. Momentum favours further upside here.
The WGS price prediction for 2035 points to an average of $488.24 (low $284.29, high $887.45) — a potential gain of +604% on today's $69.39. Buyers look set to stay in control over this stretch.
In 2040, WGS is projected to trade between $433.45 and $1,662.65, averaging $842.73 — a potential gain of +11.1x from today's $69.39. That is up +73% on the projected 2035 average. Momentum favours further upside here.
GeneDx Holdings Corp.'s 2050 outlook centres on $1,538.86, within a $692.49 to $3,411.66 range. That is up +83% on the projected 2040 average. That marks a +21.2x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in WGS today (≈ 14.411298 WGS) could be worth
$22,176.92
+$21,176.92 (+2118%) by 2050 · US Dollar
Based on the average projected WGS price of $1,538.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in WGSwould be worth at today's price.
$1,000 invested in WGS on Jul 10, 2025 (≈ 11.506155 WGS) would be worth
$798.41
-$201.59 (-20.2%) today · 0.80× · US Dollar
Based on a WGS entry price of $86.91 vs. today's $69.39.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $67.51 | $1,027.85 | +2.8% |
| 1 month ago | $54.32 | $1,277.43 | +27.7% |
| 3 months ago | $59.62 | $1,163.87 | +16.4% |
| 6 months ago | $119.24 | $581.94 | -41.8% |
| 1 year ago | $86.91 | $798.41 | -20.2% |
| All time (5.0y) ago | $420.42 | $165.05 | -83.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our WGS forecast.
Our base-case forecast reaches $140.00 around 2028.
Implied market cap at $140.00: $4.16B
The multi-year forecast shows a clear path of rising value with substantial upside over time. For 2030, the average price is projected at $209.50 with a max of $350.77 and a min of $135.13, yielding an estimated ROI of 205.1% and a bullish sentiment.
In 2040, the forecast projects an average of $861.18, a max of $1,793.01, and a min of $401.84, with an extraordinary ROI of 1154.1% and a bullish sentiment. By 2050, the average is forecast at $1,513.22, with a max of $3,480.42 and a min of $680.95, implying an ROI of 2103.6% and continued bullish sentiment.
The earlier years show a gradual ramp as well, with 2026 averaging $68.67 (min $34.51, max $94.72, ROI 0, sentiment Neutral) and 2027–2032 progressively climbing toward the higher decades, reflecting sustained upside potential and evolving market expectations. These figures are estimates and carry inherent uncertainty and risk; they are not guarantees of future performance.
Tap a question to reveal the answer.
In 2030, the forecasted min price is $135.13, the avg price is $209.50, and the max price is $350.77, with an ROI of 205.1% and a bullish sentiment.
Forecasts show bullish sentiment from 2027 onward with substantial upside, including an average price of $209.50 in 2030 and an ROI of 205.1%. However, these are estimates and not guarantees.
Yes. The 2027 forecast lists an average price of $115.85 with a max of $168.90, indicating potential to exceed $100 in that year.
The long-term view points to strong upside: 2030 avg $209.50 (ROI 205.1%), 2040 avg $861.18 (ROI 1154.1%), and 2050 avg $1,513.22 (ROI 2103.6%).
The asset shows high volatility with an annualized volatility of 90.
GeneDx Holdings Corp. Community Discussion
0Share your GeneDx Holdings Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.